ViiV Healthcare is proud to have a presence at the 22nd International Conference on AIDS and STIs in Africa (ICASA) in Harare, Zimbabwe, from 4-9 December 2023. ICASA is an important conference and provides a strong platform for leaders, scientists, activists and community in Africa to come together to advance the HIV response.

As with any congress that we attend, we will be engaging with healthcare professionals and community advocates on our mission to ensure no person living with HIV is left behind. We know we cannot end the epidemic without community partnership, and uplifting communities and community leadership are at the heart of what we do at ViiV. Working with communities affected by HIV – across Europe, Africa, North America, Asia-Pacific and Latin America – has been central to our mission since our creation and prior to that by our majority shareholder, GSK, including through Positive Action – a 30+ year, community-focused programme striving to achieve healthy communities in a world free of AIDS.

At ICASA, we will be reflecting on our commitment to address the diverse and evolving needs of the HIV community and we are proud to be involved in various platforms championing the role of communities, including sessions on:

  • Transactional sex or sex work? Does it really matter in meeting the HIV prevention needs of young girls and women?
    This ViiV symposium is co-hosted with UNAIDS on the topic of adolescent girls and young women involved in transactional sex. It will explore the topic of how do we ensure this often-overlooked population has their HIV prevention needs met?
  • The role of partnership in ending paediatric AIDS.
    This ViiV session will showcase the value of multi-sectoral and cross-functional partnerships in ending paediatric AIDS and ensuring no child or adolescent living with HIV is left behind. Speakers include a paediatric HIV healthcare specialist and representatives from The Global Network of People Living with HIV (GNP+), The Global Alliance and The Africa REACH Leadership Council.

Click here to find out more about ICASA and the programme for the 2023 conference.


Thanks to advances in science and innovation, people living with HIV have options for effective treatment that mean they can expect to live long and healthy lives. Find out why understanding the needs and wants of people living with HIV is essential.

Read about our approach to developing new medicines for people living with HIV and the life-changing impact new medicines can have on PLHIV.

It is now established that if you’re on treatment and have an undetectable viral load, you cannot pass on HIV through sex. Undetectable = Untransmittable, or U=U. This simple equation has profound implications for everyone living with HIV, and for economies and governments around the world. 


Get access to the latest press releases, company statements, and the main conferences and events about HIV and AIDS.

ViiV Exchange is our online portal for Healthcare Professionals; allowing access to latest data and information in relation to our HIV medicines.

Learning to navigate life with HIV can take time but it should not stop you from living the life you want. Read more about how to live well with HIV.


Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.